Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms.

Siren MorkenSeppo W LangerAnna SundlövLene Weber VestermarkMorten LadekarlGeir Olav HjortlandJohanna B SvenssonElizaveta Mitkina TabaksblatTorjan Magne HaslerudJörg AssmusSönke DetlefsenAnne CouvelardAurel PerrenHalfdan Sorbye

Published in: British journal of cancer (2023)

ClinicalTrials.gov (NTC02248012).

Keyphrases

phase ii study
high grade
squamous cell carcinoma
low grade
locally advanced
open label
neuroendocrine tumors
small cell lung cancer
newly diagnosed
placebo controlled
clinical trial